Baader Bank Aktiengesellschaft Has $404,000 Stock Holdings in Tilray Inc (NASDAQ:TLRY)

Baader Bank Aktiengesellschaft lowered its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 6.7% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 304,017 shares of the company’s stock after selling 21,920 shares during the period. Baader Bank Aktiengesellschaft’s holdings in Tilray were worth $404,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also modified their holdings of the business. BNP Paribas Financial Markets lifted its holdings in shares of Tilray by 1,314.1% in the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock worth $3,202,000 after acquiring an additional 1,690,827 shares during the last quarter. Point72 Asset Management L.P. acquired a new stake in shares of Tilray during the third quarter valued at about $1,348,000. Bank of Montreal Can increased its stake in shares of Tilray by 19.6% in the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after buying an additional 355,778 shares during the period. Creative Planning boosted its position in Tilray by 36.6% during the 3rd quarter. Creative Planning now owns 141,921 shares of the company’s stock worth $250,000 after buying an additional 38,054 shares during the period. Finally, The Manufacturers Life Insurance Company lifted its holdings in Tilray by 11.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 682,478 shares of the company’s stock worth $1,131,000 after buying an additional 70,605 shares during the period. 9.35% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently commented on the company. Canaccord Genuity Group upped their target price on Tilray from $2.00 to $3.00 and gave the company a “buy” rating in a report on Monday, January 13th. Roth Mkm lowered their target price on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $2.70.

Tilray Price Performance

Tilray stock opened at $1.13 on Friday. The company has a quick ratio of 1.58, a current ratio of 2.54 and a debt-to-equity ratio of 0.10. The firm’s fifty day moving average price is $1.28 and its two-hundred day moving average price is $1.56. Tilray Inc has a 1-year low of $1.03 and a 1-year high of $2.97.

Tilray (NASDAQ:TLRY) last posted its quarterly earnings results on Friday, January 10th. The company reported ($0.10) earnings per share for the quarter, missing the consensus estimate of ($0.03) by ($0.07). The company had revenue of $210.90 million for the quarter, compared to the consensus estimate of $216.34 million. Tilray had a negative net margin of 30.95% and a negative return on equity of 4.40%. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. Research analysts expect that Tilray Inc will post -0.2 EPS for the current year.

Insider Buying and Selling at Tilray

In other news, CFO Carl A. Merton acquired 26,000 shares of Tilray stock in a transaction that occurred on Friday, November 15th. The stock was bought at an average price of $1.36 per share, with a total value of $35,360.00. Following the completion of the purchase, the chief financial officer now owns 26,000 shares in the company, valued at approximately $35,360. The trade was a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. 0.87% of the stock is owned by corporate insiders.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.